Linyi, China

Sina Pan

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Lunan Pharmaceutical Group Corporation. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sina Pan. Retrieved from https://idiyas.com/inventor/sina-pan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Sina Pan

Introduction

Sina Pan is a notable inventor based in Linyi, China. He has made significant contributions to the field of medicine, particularly through his innovative research and development of therapeutic applications.

Latest Patents

Sina Pan holds a patent for the medical use of icaritin. This patent outlines the use of icaritin in preparing a drug aimed at preventing and treating bleeding disorders. The invention is particularly relevant for its ability to relieve platelet dysfunction, shorten thromboplastin time, and promote blood coagulation. It is especially useful in treating hemorrhagic transformation after cerebral infarction, gastrointestinal bleeding caused by thrombolytic or antithrombotic drugs for cerebral infarction, and bleeding complications associated with myocardial infarction. He has 1 patent to his name.

Career Highlights

Sina Pan is affiliated with Lunan Pharmaceutical Group Corporation, where he applies his expertise in medical research. His work has been instrumental in advancing therapeutic options for patients suffering from bleeding disorders.

Collaborations

Sina collaborates with esteemed colleagues, including Jingchun Yao and Chenghong Sun, to further enhance the impact of his research and innovations.

Conclusion

Sina Pan's contributions to medical science through his patent on icaritin exemplify the importance of innovation in addressing critical health issues. His work continues to pave the way for advancements in treatment options for bleeding disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…